Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism

Chen G, Xue Y, Zhang Q, Xue T, Yao J, Huang H, Liang J, Li L, Lin W, Lin L, Shi L, Cai L, Wen J (2015) Is normocalcemic primary hyperparathyroidism harmful or harmless? J Clin Endocrinol Metab 100(6):2420–2424. https://doi.org/10.1210/jc.2014-4432

Article  CAS  PubMed  Google Scholar 

Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML (2022) International Workshop on Primary Hyperparathyroidism. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res 37(11):2293–2314. doi: https://doi.org/10.1002/jbmr.4677

Pepe J, Cipriani C, Sonato C, Raimo O, Biamonte F, Minisola S (2017) Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol 177(6):R297–R308. https://doi.org/10.1530/EJE-17-0485

Article  CAS  PubMed  Google Scholar 

Chiodini I, Cairoli E, Palmieri S, Pepe J, Walker MD (2018) Non classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32(6):805–820. https://doi.org/10.1016/j.beem.2018.06.006

Article  CAS  PubMed  Google Scholar 

Pepe J, Colangelo L, Sonato C, Occhiuto M, Ferrara C, Del Fattore A, Santori R, Mastrantonio M, Sgreccia A, Minisola S, Cipriani C (2021) Echocardiographic findings in patients with normocalcemic primary hyperparathyroidism compared with findings in hypercalcemic primary hyperparathyroid patients and control subjects. Endocr Pract 27(1):21–26. https://doi.org/10.4158/EP-2020-0405

Article  PubMed  Google Scholar 

Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M, Cakal E (2019) Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord 19(1):106. https://doi.org/10.1186/s12872-019-1093-4

Article  PubMed  PubMed Central  Google Scholar 

Mesquita PN, Dornelas Leão Leite AP, Chagas Crisóstomo SD, da Veras Filho E, Cunha Xavier L, Bandeira F (2017) Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism. Vasc Health Risk Manag 13:225–229. https://doi.org/10.2147/VHRM.S128084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stewart LA, Steinl GK, Huang BL, McManus C, Lee JA, Kuo JH, Walker MD (2022) Primary hyperparathyroidism is associated with shorter qtc intervals, but not arrhythmia. J Clin Endocrinol Metab 107(4):e1689–e1698. https://doi.org/10.1210/clinem/dgab820

Article  PubMed  Google Scholar 

Pepe J, Curione M, Morelli S, Pepe J, Curione M, Morelli S, Colotto M, Varrenti M, Castro C, D’Angelo A, Cipriani C, Piemonte S, Romagnoli E, Minisola S (2013) Arrhythmias in primary hyperparathyroidism evaluated by exercise test. Eur J Clin Invest 43:208–214. https://doi.org/10.1111/eci.12038

Article  CAS  PubMed  Google Scholar 

Pepe J, Curione M, Morelli S, Varrenti M, Cammarota C, Cilli M, Piemonte S, Cipriani C, Savoriti C, Raimo O, De Lucia F, Colangelo L, Clementelli C, Romagnoli E, Minisola S (2013) Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test. Eur J Endocrinol 169:255–261. https://doi.org/10.1530/EJE-13-0293

Article  CAS  PubMed  Google Scholar 

Pepe J, Cipriani C, Curione M, Biamonte F, Colangelo L, Danese V, Cecchetti V, Sonato C, Ferrone F, Cilli M, Minisola S (2018) Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24-h ECG monitoring. Eur J Endocrinol 179(2):117–124. https://doi.org/10.1530/EJE-17-0948

Article  CAS  PubMed  Google Scholar 

Van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA (2013) Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies. Am Heart J 165:655–664. https://doi.org/10.1016/j.ahj.2013.02.014

Article  CAS  PubMed  Google Scholar 

Andersson P, Rydberg E, Willenheimer R (2004) Primary hyperparathyroidism and heart disease: a review. Eur Heart J 25:1776e87. https://doi.org/10.1016/j.ehj.2004.07.010

Article  CAS  Google Scholar 

Ogino K, Burkhoff D, Bilezikian JP (1995) The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136:3024e30. https://doi.org/10.1210/endo.136.7.7789328

Article  Google Scholar 

Trevisan C, Piovesan F, Lucato P, Zanforlini BM, De Rui M, Maggi S, Noale M, Corti MC, Perissinotto E, Manzato E, Sergi G (2019) Parathormone, vitamin D and the risk of atrial fibrillation in older adults: a prospective study. Nutr Metab Cardiovasc Dis 29(9):939–945. https://doi.org/10.1016/j.numecd.2019.05.064

Article  CAS  PubMed  Google Scholar 

Folsom AR, Alonso A, Misialek JR, Michos ED, Selvin E, Eckfeldt JH, Coresh J, Pankow JS, Lutsey PL (2014) Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 168:296e302. https://doi.org/10.1016/j.ahj.2014.04.017

Article  CAS  Google Scholar 

Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappé DL, Muhlestein JB (2011) Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 162:331e9. https://doi.org/10.1016/j.ahj.2011.05.005.e2

Article  Google Scholar 

Argirò R, Diacinti D, Sacconi B, Iannarelli A, Diacinti D, Cipriani C, Pisani D, Romagnoli E, Biffoni M, Di Gioia C, Pepe J, Bezzi M, Letizia C, Minisola S, Catalano C (2018) Diagnostic accuracy of 3T magnetic resonance imaging in the preoperative localisation of parathyroid adenomas: comparison with ultrasound and 99mTc-sestamibi scans. Eur Radiol 28(11):4900–4908. https://doi.org/10.1007/s00330-018-5437-8

Article  PubMed  Google Scholar 

Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. JBMR 9:1137–1148. https://doi.org/10.1002/jbmr.5650080915

Article  Google Scholar 

Tordjman KM, Yaron M, Izkhakov E, Osher E, Shenkerman G, Marcus-Perlman Y, Stern N (2010) Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol 162(5):925–933. https://doi.org/10.1530/EJE-09-1067

Article  CAS  PubMed  Google Scholar 

Koubaity O, Mandry D, Nguyen-Thi PL, Bihain F, Nomine-Criqui C, Demarquet L, Croise-Laurent V, Brunaud L (2020) Coronary artery disease is more severe in patients with primary hyperparathyroidism. Surg (United States) 167(1):149–154. https://doi.org/10.1016/j.surg.2019.05.094

Article  Google Scholar 

Pepe J, Diacinti D, Fratini E, Nofroni I, D’Angelo A, Pilotto R, Savoriti C, Colangelo L, Raimo O, Cilli M, Cipriani C, Minisola S (2016) High prevalence of abdominal aortic calcification in patients with primary hyperparathyroidism as evaluated by Kauppila score. Eur J Endocrinol 175:95–100. https://doi.org/10.1530/EJE-15-1152

Article  CAS  PubMed  Google Scholar 

Pepe J, Cipriani C, Tedeschi M, Curione M, Parravano M, Varano M, Biamonte F, Colangelo L, Minisola S (2018) Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism. Sci Rep 1:16521. https://doi.org/10.1038/s41598-018-35017-y

Article  CAS  Google Scholar 

Walker MD, Rundek T, Homma S, Ditullio M, Iwata S, Lee JA, Choi J, Liu R, Zhang C, McMahon DJ et al (2012) Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism. Eur J Endocrinol 167:277–285. https://doi.org/10.1530/EJE-12-0124

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pepe J, Cipriani C, Pilotto R, De Lucia F, Castro C, Lenge L, Russo S, Guarnieri V, Scillitani A, Carnevale V, Erasmo E, Romagnoli E, Minisola S (2011) Sporadic and hereditary primary hyperparathyroidism. J Endocrinol Invest 34:40–44

CAS  PubMed  Google Scholar 

De Lucia F, Minisola S, Romagnoli E, Pepe J, Cipriani C, Scillitani A, Parikh N, Rao DS (2013) Effect of gender and geographic location on the expression of primary hyperparathyroidism. J Endocrinol Invest 36(2):123–126. https://doi.org/10.3275/8455

Article  CAS  PubMed  Google Scholar 

Minisola S, Arnold A, Belaya Z, Brandi ML, Clarke BL, Hannan FM, Hofbauer LC, Insogna KL, Lacroix A, Liberman U, Palermo A, Pepe J, Rizzoli R, Wermers R, Thakker RV (2022) Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism. J Bone Miner Res 37(11):2315–2329. https://doi.org/10.1002/jbmr.4665

Article  PubMed  Google Scholar 

Comments (0)

No login
gif